EDP Biotech announced preliminary results of its ColoPlex biomarker study involving 1,499 patients at the American Society of Clinical Oncology (ASCO) Virtual 2020 conference May 29th – 31st. Abstract #:e16145 was published in the Gastrointestinal cancer session and track. More details can be found below.
Fritsche, H.A., et.al. “Serum-based multiplex protein assay for early detection of colorectal cancer and precancerous lesions in a FIT positive population.” J Clin Oncol 38: 2020 (suppl; abstr e16145)
DOI:10.1200/JCO.2020.38.15_suppl.e16145
The full published abstract can be found HERE